The significance of N-linked glycosylation in pig endogenous retrovirus infectivity

Biochemical and Biophysical Research Communications

Volumn 310, Issue 2, 2003, Pages 327-333

  Hazama, Kenji ^a   Miyagawa, Shuji ^a   Miyazawa, Takayuki ^b,c   Yamada, Junko ^a   Tomonaga, Keizo ^d   Ota, Mitsunori ^a   Matsuda, Hikaru ^a   Shirakura, Ryota ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Mannose; N linked sugar; Pig endogenous retrovirus; Xenotransplantation

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; 1 DEOXYNOJIRIMYCIN; CASTANOSPERMINE; ENVELOPE PROTEIN; GLUCOSE; GLYCAN DERIVATIVE; GLYCOPROTEIN; MANNOSIDASE INHIBITOR; SUGAR; SWAINSONINE; TUNICAMYCIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL STRAIN; CULTURE MEDIUM; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; HUMAN CELL; INOCULATION; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; RETROVIRUS INFECTION; STAINING; SWINE; TERMINAL SEQUENCE; UPREGULATION; VIRUS TRANSMISSION;

PIG ENDOGENOUS RETROVIRUS; SUS SCROFA; UNIDENTIFIED RETROVIRUS;

EID: 0141793915     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.142     Document Type: Article

References (27)

1. Patience C., Takeuchi Y., Weiss R.A. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3:1997;282-286.
2. Wilson C.A., Wong S., Muller J., Davidson C.E., Rose T.M., Burd P. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J. Virol. 72:1998;3082-3087.
3. van der Laan L.J.W., Lockey C., Griffeth B.C., Frasier F.S., Wilson C.A., Onions D.E., Hering B.J., Long Z., Otto E., Torbett B.E., Salomon D.R. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature. 407:2000;90-94.
4. Deng Y.M., Tuch B.E., Rawlinson W.D. Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation. 70:2000;1010-1016.
5. Switzer W.M., Michler R.E., Shanmugam V., Matthews A., Hussain A.I., Wright A., Sandstrom P., Chapman L.E., Weber C., Safley S., Denny R.R., Navarro A., Evans V., Norin A.J., Kwiatkowski P., Heneine W. Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation. 71:2001;959-965.
6. Paradis K., Langford G., Long Z., Heneine W., Sandstrom P., Switzer W.M., Chapman L.E., Lockey C., Onions D., Otto E. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science. 285:1999;1236-1241.
7. Oldmixon B.A., Wood J.C., Ericsson T.A., Wilson C.A., White-Scharf M.E., Andersson G., Greenstein J.L., Schuurman H.J., Patience C. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J. Virol. 76:2002;3045-3048.
8. Blusch J.H., Patience C., Martin U. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation. 9:2002;242-251.
9. Qari S.H., Magre S., Garcia-Lerma J.G., Hussain A.I., Takeuchi Y., Patience C., Weiss R.A., Heneine W. Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. J. Virol. 75:2001;1048-1053.
10. Stephan O., Schwendemann J., Specke V., Tacke S.J., Boller K., Denner J. Porcine endogenous retroviruses (PERVs): generation of specific antibodies, development of an immunoperoxidase assay (IPA) and inhibition by AZT. Xenotransplantation. 8:2001;310-316.
11. Fiebig U., Stephan O., Kurth R., Denner J. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology. 307:2003;406-413.
12. T. Kurihara, T. Miyazawa, S. Miyagawa, K. Tomonaga, K. Hazama, J. Yamada, R. Shirakura, Y. Matsuura, Sensitivity to human serum of gammaretroviruses produced from pig endothelial cells transduced with glycosyltransferase genes, Xenotransplantation (in press).
13. Leonard C.K., Spellman M.W., Riddle L., Harris R.J., Thomas J.N., Gregory T.J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:1990;10373-10382.
14. Lee W.R., Syu W.J., Du B., Matsuda M., Tan S., Wolf A., Essex M., Lee T.H. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 89:1992;2213-2217.
15. Yeh J.C., Seals J.R., Murphy C.I., van Halbeek H., Cummings R.D. Site-specific N-glycosylation and oligosaccharide structures of recombinant HIV-1 gp120 derived from a baculovirus expression system. Biochemistry. 32:1993;11087-11099.
16. Bolmstedt A.J., O'Keefe B.R., Shenoy S.R., McMahon J.B., Boyd M.R. Cyanovirin-N defines a new class of antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner. Mol. Pharmacol. 59:2001;949-954.
17. Le Tissier P., Stoye J.P., Takeuchi Y., Patience C., Weiss R.A. Two sets of human-tropic pig retrovirus. Nature. 389:1997;681-682.
18. Miyagawa S., Shirakura R., Iwata K., Nakata S., Matsumiya G., Izutani H., Matsuda H., Terado A., Matsumoto M., Nagasawa S. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAF hybrid, on complement-mediated swine endothelial cell lysis. Transplantation. 58:1994;834-840.
19. Tailor C.S., Takeuchi Y., O'Hara B., Johann S.V., Weiss R.A., Collins M.K. Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections. J. Virol. 67:1993;6737-6741.
20. Koma M., Miyagawa S., Honke K., Ikeda Y., Koyota S., Miyoshi S., Matsuda H., Tsuji S., Shirakura R., Taniguchi N. Reduction of the major xenoantigen on glycosphingolipids of swine endothelial cells by various glycosyltransferases. Glycobiology. 10:2000;745-751.
21. Miyagawa S., Nakai R., Matsunami K., Kusama T., Shirakura R. Co-effect of HLA-G1 and glycosyltransfeses in reducing NK cell-mediated pig endothelial cell lysis. Transplant. Immunol. 11:2003;147-153.
22. Baenziger J.U., Fiete D. Structural determinants of concanavalin A specificity for oligosaccharides. J. Biol. Chem. 254:1979;2400-2407.
23. Gruters R.A., Neefjes J.J., Tersmette Z.M., de Goede R.E., Tulp A., Huisman H.G., Miedema F., Ploegh H.L. Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature. 330:1987;74-77.
24. Pal R., Hoke G.M., Sarngadharan M.G. Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 86:1989;3384-3388.
25. Robinson W.E. Jr., Montefiori D.C., Mitchell W.M., Prince A.M., Alter H.J., Dreesman G.R., Eichberg J.W. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees. Proc. Natl. Acad. Sci. USA. 86:1989;4710-4714.
26. Hu H., Shioda T., Moriya C., Xin X., Hasan M.K., Miyake K., Shimada T., Nagai Y. Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface. J. Virol. 70:1996;7462-7470.
27. Means R.E., Desrosiers R.C. Resistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases. J. Virol. 74:2000;11181-11190.